- Home
- BKH vs PTCT Comparison
BKH vs PTCT Comparison
Compare BKH & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKH
- PTCT
- Stock Information
- Founded
- BKH 1941
- PTCT 1998
- Country
- BKH United States
- PTCT United States
- Employees
- BKH N/A
- PTCT N/A
- Industry
- BKH Electric Utilities: Central
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- BKH Utilities
- PTCT Health Care
- Exchange
- BKH Nasdaq
- PTCT Nasdaq
- Market Cap
- BKH 4.3B
- PTCT 3.7B
- IPO Year
- BKH N/A
- PTCT 2013
- Fundamental
- Price
- BKH $58.54
- PTCT $50.69
- Analyst Decision
- BKH Hold
- PTCT Buy
- Analyst Count
- BKH 4
- PTCT 13
- Target Price
- BKH $63.75
- PTCT $62.31
- AVG Volume (30 Days)
- BKH 454.1K
- PTCT 1.4M
- Earning Date
- BKH 07-30-2025
- PTCT 05-06-2025
- Dividend Yield
- BKH 4.61%
- PTCT N/A
- EPS Growth
- BKH N/A
- PTCT N/A
- EPS
- BKH 3.95
- PTCT 7.51
- Revenue
- BKH $2,206,500,000.00
- PTCT $1,772,758,000.00
- Revenue This Year
- BKH $4.90
- PTCT $121.50
- Revenue Next Year
- BKH $3.27
- PTCT N/A
- P/E Ratio
- BKH $14.82
- PTCT $6.75
- Revenue Growth
- BKH 3.28
- PTCT 91.12
- 52 Week Low
- BKH $51.66
- PTCT $28.72
- 52 Week High
- BKH $65.59
- PTCT $58.38
- Technical
- Relative Strength Index (RSI)
- BKH 47.67
- PTCT 60.74
- Support Level
- BKH $57.37
- PTCT $44.54
- Resistance Level
- BKH $58.79
- PTCT $49.15
- Average True Range (ATR)
- BKH 0.95
- PTCT 1.85
- MACD
- BKH 0.03
- PTCT 0.58
- Stochastic Oscillator
- BKH 66.50
- PTCT 90.66
About BKH Black Hills Corporation
Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.